Sudhir Tauro

9.8k total citations
39 papers, 1.1k citations indexed

About

Sudhir Tauro is a scholar working on Hematology, Molecular Biology and Epidemiology. According to data from OpenAlex, Sudhir Tauro has authored 39 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hematology, 10 papers in Molecular Biology and 8 papers in Epidemiology. Recurrent topics in Sudhir Tauro's work include Acute Myeloid Leukemia Research (15 papers), Hematopoietic Stem Cell Transplantation (8 papers) and Acute Lymphoblastic Leukemia research (6 papers). Sudhir Tauro is often cited by papers focused on Acute Myeloid Leukemia Research (15 papers), Hematopoietic Stem Cell Transplantation (8 papers) and Acute Lymphoblastic Leukemia research (6 papers). Sudhir Tauro collaborates with scholars based in United Kingdom, United States and Sweden. Sudhir Tauro's co-authors include Charles Craddock, Premini Mahendra, Paul Moss, Michael J. Groves, Ronjon Chakraverty, Lucinda Billingham, John M. Goldman, Mark Cobbold, Mario Assenmacher and Eduardo Olavarría and has published in prestigious journals such as The Lancet, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Sudhir Tauro

37 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sudhir Tauro United Kingdom 14 475 361 338 268 234 39 1.1k
Antonio Jiménez United States 17 428 0.9× 142 0.4× 254 0.8× 148 0.6× 327 1.4× 59 944
Amedea Donelli Italy 21 390 0.8× 246 0.7× 386 1.1× 202 0.8× 324 1.4× 41 1.1k
Meagan A. Jacoby United States 18 492 1.0× 469 1.3× 539 1.6× 197 0.7× 453 1.9× 65 1.3k
Claude Baillou France 20 442 0.9× 125 0.3× 243 0.7× 467 1.7× 449 1.9× 56 1.3k
J. Joseph Melenhorst United States 18 275 0.6× 143 0.4× 348 1.0× 624 2.3× 249 1.1× 32 1.0k
A Zander Germany 17 465 1.0× 107 0.3× 420 1.2× 273 1.0× 317 1.4× 51 1.1k
Shinsuke Takagi Japan 17 808 1.7× 97 0.3× 447 1.3× 397 1.5× 352 1.5× 71 1.3k
Shaun Fleming Australia 14 412 0.9× 211 0.6× 219 0.6× 85 0.3× 302 1.3× 56 815
Jürgen Enczmann Germany 20 303 0.6× 112 0.3× 130 0.4× 454 1.7× 162 0.7× 50 1.0k
Paulo Vidal Campregher Brazil 12 429 0.9× 140 0.4× 569 1.7× 950 3.5× 323 1.4× 57 1.7k

Countries citing papers authored by Sudhir Tauro

Since Specialization
Citations

This map shows the geographic impact of Sudhir Tauro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sudhir Tauro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sudhir Tauro more than expected).

Fields of papers citing papers by Sudhir Tauro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sudhir Tauro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sudhir Tauro. The network helps show where Sudhir Tauro may publish in the future.

Co-authorship network of co-authors of Sudhir Tauro

This figure shows the co-authorship network connecting the top 25 collaborators of Sudhir Tauro. A scholar is included among the top collaborators of Sudhir Tauro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sudhir Tauro. Sudhir Tauro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tanaka, Tomoyuki, et al.. (2024). Elraglusib Induces Cytotoxicity via Direct Microtubule Destabilization Independently of GSK3 Inhibition. Cancer Research Communications. 4(11). 3013–3024. 2 indexed citations
2.
Tauro, Sudhir, et al.. (2023). Elraglusib (formerly 9-ING-41) possesses potent anti-lymphoma properties which cannot be attributed to GSK3 inhibition. Cell Communication and Signaling. 21(1). 131–131. 2 indexed citations
3.
John, M. Joseph, Philip Kuriakose, Mark P. Smith, Eve Roman, & Sudhir Tauro. (2021). The long shadow of socioeconomic deprivation over the modern management of acute myeloid leukemia: time to unravel the challenges. Blood Cancer Journal. 11(8). 141–141. 2 indexed citations
4.
Dillon, Richard, Matthew J. Ahearne, Lynn Quek, et al.. (2021). Therapy-related leukaemias with balanced translocations can arise from pre-existing clonal haematopoiesis. Leukemia. 35(8). 2407–2411. 3 indexed citations
5.
Avenoso, Daniele, Judith Marsh, Victoria Potter, et al.. (2021). SARS-CoV-2 infection in aplastic anemia. Haematologica. 107(2). 541–543. 13 indexed citations
6.
Heppel, Nicole H., Bethan Britt‐Compton, Julia W. Grimstead, et al.. (2017). Telomere length is an independent prognostic marker in MDS but not in de novo AML. British Journal of Haematology. 178(2). 240–249. 20 indexed citations
7.
Papaemmanuil, Elli, Michael J. Groves, Ann Hyslop, et al.. (2016). Impact of socioeconomic status on disease phenotype, genomic landscape and outcomes in myelodysplastic syndromes. British Journal of Haematology. 174(2). 227–234. 4 indexed citations
8.
Nikolousis, Emmanouil, Stephen Robinson, Sandeep Nagra, et al.. (2013). Post-transplant T cell chimerism predicts graft versus host disease but not disease relapse in patients undergoing an alemtuzumab based reduced intensity conditioned allogeneic transplant. Leukemia Research. 37(5). 561–565. 23 indexed citations
9.
Papaemmanuil, Elli, Moritz Gerstung, Luca Malcovati, et al.. (2013). O-001 Clinical and biological implications of gene mutations in MDS. Leukemia Research. 37. S9–S9. 1 indexed citations
10.
MacCallum, Stephanie F., Michael J. Groves, John James, et al.. (2013). Dysregulation of autophagy in chronic lymphocytic leukemia with the small-molecule Sirtuin inhibitor Tenovin-6. Scientific Reports. 3(1). 1275–1275. 29 indexed citations
11.
Groves, Michael J., Stephanie F. MacCallum, Joan Cunningham, et al.. (2012). Heterogeneity of p53-pathway Protein Expression in Chemosensitive Chronic Lymphocytic Leukemia: A Pilot Study. Journal of Cancer. 3. 354–361. 3 indexed citations
12.
Groves, Michael J., Mark Sales, Lee D. Baker, et al.. (2011). Factors influencing a second myeloid malignancy in patients with Philadelphia-negative -7 or del(7q) clones during tyrosine kinase inhibitor therapy for chronic myeloid leukemia. Cancer Genetics. 204(1). 39–44. 10 indexed citations
13.
Hyslop, Ann, et al.. (2011). Predicted costs of iron‐chelators in myelodysplastic syndromes: A 10‐year analysis based on actual prevalence and red cell transfusion rates. American Journal of Hematology. 86(5). 406–410. 11 indexed citations
14.
Foster, Nicola, Kajsa Paulsson, Mark Sales, et al.. (2010). Molecular characterisation of a recurrent, semi‐cryptic RUNX1 translocation t(7;21) in myelodysplastic syndrome and acute myeloid leukaemia. British Journal of Haematology. 148(6). 938–943. 19 indexed citations
15.
Craig, Jeffrey W., et al.. (2008). Multifocal primary extranodal B-cell non-Hodgkin’s lymphoma involving six extranodal sites: Figure 1. Journal of Clinical Pathology. 62(1). 89–91. 1 indexed citations
16.
17.
Tauro, Sudhir, et al.. (2003). High-hyperdiploidy in Philadelphia positive adult acute lymphoblastic leukaemia: case-series and review of literature. Bone Marrow Transplantation. 31(9). 763–766. 4 indexed citations
18.
Tauro, Sudhir, Gulnaz Begum, J Craig, et al.. (2003). Stem cell transplantation after salvage therapy with high-dose cytarabine and amsacrine in adults with high-risk leukaemia. Bone Marrow Transplantation. 32(3). 273–278. 4 indexed citations
19.
Tauro, Sudhir & Premini Mahendra. (2001). Resolution of sarcoidosis after allogeneic bone marrow transplantation with donor lymphocyte infusions. Bone Marrow Transplantation. 27(7). 757–759. 9 indexed citations
20.
Tauro, Sudhir, et al.. (2000). Recurrent penicillin-resistant pneumococcal sepsis after matched unrelated donor (MUD) transplantation for refractory T cell lymphoma. Bone Marrow Transplantation. 26(9). 1017–1019. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antonio Jiménez Breakdown of academic impact, for papers by Amedea Donelli Breakdown of academic impact, for papers by Meagan A. Jacoby Breakdown of academic impact, for papers by Claude Baillou Breakdown of academic impact, for papers by J. Joseph Melenhorst Breakdown of academic impact, for papers by A Zander Breakdown of academic impact, for papers by Shinsuke Takagi Breakdown of academic impact, for papers by Shaun Fleming Breakdown of academic impact, for papers by Jürgen Enczmann Breakdown of academic impact, for papers by Paulo Vidal Campregher
Rankless by CCL
2026